Cooper S F, Massé R, Dugal R
Canadian Center for Doping Control, Institut National de la Recherche Scientifique (INRS-Santé), Université du Québec, Pointe-Claire, Canada.
J Chromatogr. 1989 Apr 7;489(1):65-88. doi: 10.1016/s0378-4347(00)82884-4.
A rapid and reliable screening procedure using high-performance liquid chromatography for the detection of 23 diuretics (belonging to five different pharmacological groups) in urine has been developed. Two aliquots of 2-ml urine samples were extracted separately under acidic and basic conditions. The acidic and basic extracts were pooled, evaporated to dryness and reconstituted in methanol. The methanolic extract was injected onto a Hewlett-Packard Hypersil ODS C18 (5 microns) column (column I) and a Hewlett-Packard LiChrosorb RP-18 (5 microns) column (column II; an alternative column). The same gradient mobile phase was used for both columns. A diode array ultraviolet detector was set to monitor the signal to the integrator (Chem Station) at 230 and 275 nm. Recovery studies of the 23 diuretics were performed under acidic and basic conditions. The overall lower limits for detection on column I using both extraction procedures ranged from 0.5 to 1.5 micrograms/ml of urine (average 1.0 micrograms/ml). Amiloride, ethacrynic acid and probenecid could not be detected below 5 micrograms/ml of urine. No interference from the biological matrix was apparent. Amiloride could be detected in urine 4 h after oral administration of 15 mg of amiloride to a healthy volunteer, when the sample was extracted under alkaline conditions. The suitability of the screening method for the analysis of urine samples was tested by studying the variation with time of chlorthalidone, furosemide, probenecid, acetazolamide, quinethazone, spironolactone, bendroflumethiazide, bumetanide, triameterene and hydrochlorothiazide concentrations in the urine of normal human volunteers after minimum single or multiple (probenecid) doses.(ABSTRACT TRUNCATED AT 250 WORDS)
已开发出一种快速可靠的筛查程序,使用高效液相色谱法检测尿液中的23种利尿剂(属于五个不同药理组)。将两份2毫升尿液样本的等分试样分别在酸性和碱性条件下提取。将酸性和碱性提取物合并,蒸发至干并在甲醇中复溶。将甲醇提取物注入惠普Hypersil ODS C18(5微米)柱(柱I)和惠普LiChrosorb RP - 18(5微米)柱(柱II;替代柱)。两根柱使用相同的梯度流动相。设置二极管阵列紫外检测器在230和275纳米处监测信号至积分仪(化学工作站)。在酸性和碱性条件下对23种利尿剂进行了回收率研究。使用两种提取程序在柱I上的总体检测下限范围为0.5至1.5微克/毫升尿液(平均1.0微克/毫升)。在低于5微克/毫升尿液时,氨氯吡脒、依他尼酸和丙磺舒无法检测到。未观察到生物基质的干扰。当在碱性条件下提取样品时,给一名健康志愿者口服15毫克氨氯吡脒后4小时,可在尿液中检测到氨氯吡脒。通过研究正常人志愿者在单次或多次(丙磺舒)最小剂量后尿液中氯噻酮、呋塞米、丙磺舒、乙酰唑胺、喹乙宗、螺内酯、苄氟噻嗪、布美他尼、氨苯蝶啶和氢氯噻嗪浓度随时间的变化,测试了该筛查方法对尿液样本分析的适用性。(摘要截断于250字)